Arkolith/Insider Trading/DRMA/Form 4

Van Hoose Kyri K.

SVP, CFODermata Therapeutics, Inc. (DRMA) · full profile →Form 4 · filed Dec 29, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2025Grant(A)123K——130K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 23, 2025Grant(A)8K——8K
Dec 23, 2025Grant(A)123K——123K
Dec 23, 2025Disposed to issuer(D)8K——0
Dec 23, 2025Grant(A)123K——123K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-029470) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML